29 December 2025 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Introduction. The article focuses on exploring the possibilities of intermittent hypoxia-hyperoxia therapy (IHHT) as an effective and safe method for neurorehabilitation of patients who have suffered severe brain injuries and remain in a state of chronic critical illness. Literature review of scientific publications indicates that IHHT can activate important adaptive mechanisms, modulate antioxidant pathways, improve mitochondrial function, and stimulate neuroplasticity. The objective was to review current data on the mechanisms of intermittent hypoxia-hyperoxia therapy and evaluate its potential as a treatment and rehabilitation strategy for patients with chronic critical illness following severe cerebrovascular events in neurological intensive care units. Materials and Methods. We conducted a literature review using databases such as Web of Science, Scopus, PubMed, RSCI, and eLibrary. The analysis included 43 sources presenting up-to-date clinical and experimental approaches to the use of IHHT, its underlying mechanisms, and efficacy assessment. In addition, the article also includes the authors’ ICU experience with IHHT in chronically critically ill patients following severe cerebral catastrophes. Results. IHHT has been shown to activate several key adaptive mechanisms, including the expression of HIF-1α (Hypoxia-inducible factor 1-alpha) and HIF-2α (Hypoxia-inducible factor 2-alpha), modulation of antioxidant pathways involving Nrf2 (Nuclear factor erythroid 2-related factor 2), improvement of mitochondrial function, stimulation of angiogenesis and neuroplasticity. Positive clinical effects are observed when therapy parameters are carefully individualized and safety is closely monitored. The method shows promising potential for integration into personalized therapeutic and rehabilitation protocols in intensive care settings. Conclusion. Intermittent hypoxia-hyperoxia therapy represents a promising adjunctive approach for ICU patients with sequelae of severe cerebral catastrophes, enhancing endogenous recovery mechanisms. In the future, multicenter clinical studies are required to standardize the method, refine indications and contraindications, and develop clinical protocols for its use in intensive care.
29 June 2025 in Physical and rehabilitation medicine, medical rehabilitation
ИВИльин Дмитрий Владиленович
Ильин Дмитрий Владиленович
+1
The term “chronic critical illness” was first coined in 1985 by researchers at Stanford University School of Medicine in an article with the provocative headline “Save or let die?” The authors described a unique category of patients that stood out among the general population of patients in intensive care units. These patients, who received a full range of intensive care, did not die, but also did not achieve recovery for weeks, months, or even years after an acute Injury. This research opened doors for further study. National and foreign sources show that patients with chronic critical illness comprise 5–20% of intensive care unit patients. Despite intensive treatment and rehabilitation measures, most of these patients eventually develop homeostasis disorders and complications, leading to multiple organ failure and death. This article presents an intermittent hypoxia-hyperoxia therapy case study for a patient with the chronic disorder of consciousness. The patient completed two weeks of intensive care therapy at the Scientific Research Institute of rehabilitation named after Prof. Pryanikova I.V. of the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology. Metered-dose intermittent hypoxia-hyperoxia therapy training improved the patient’s adaptation and reduced neurological deficits as a part of comprehensive rehabilitation. Intermittent hypoxic-hyperoxia therapy shows potential in the intensive care unit patient treatment and in rehabilitation.